Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
Build it Boldly, and Pharma Will Come—and More Wisdom from Boston’s Biotech and Pharma Elite at Xconomy Forum Ryan McBride 11/05/09 Boston
Vertex and Ironwood Drugs Fare Well in Clinical Trials, Pulmatrix Breathes in $30.2M, IRobot Launches Healthcare Unit, & More Boston-Area Life Sciences News Rebecca Zacks 11/04/09 Boston
Student Dissertation Launches San Diego Life Sciences Tools Company, Sirigen Denise Gellene 11/04/09 San Diego
Idenix Shares Drop as Novartis Walks Away From Hepatitis C Drug Luke Timmerman 10/30/09 Boston
Public Biotechs’ Finances Foundering, Epizyme Banks $32M, Paratek Cuts Deal with Novartis, & More Boston-Area Life Sciences News Rebecca Zacks 10/09/09 Boston
Ironwood Recruits Genentech, Facebook Star as Company Knocks on Wall Street Doors Luke Timmerman 10/05/09 Boston
Botox’s Singh Moves on to San Diego’s Transdel, Developer of Pain Reliever to Rival Advil Luke Timmerman 09/28/09 San Diego
Autism Gets a Boost: Seaside Therapeutics Raises $30M To Develop First Drugs That Might Work Luke Timmerman 09/17/09 Boston
Ascent Therapeutics’ Blood Cancer Drug Could Rival Genzyme’s Mozobil Ryan McBride 09/16/09 Boston
Ambit Biosciences, In Third Incarnation, Gears Up for Pivotal Study of Leukemia Drug Luke Timmerman 09/10/09 San Diego
Orexigen Aims to Redefine Obesity, as Amgen Vet Revamps Company to Compete Luke Timmerman 09/02/09 San Diego
Intellikine, Stocked With Cash, Pushes Portfolio of Drugs Against Biology’s Hot Targets Luke Timmerman 08/18/09 San Diego
Seattle Genetics, Bucking the Trend, Recruits Hodgkin’s Patients at Warp Speed Luke Timmerman 08/12/09 Seattle
Vertex Scores $105M For Asian Telaprevir Rights, Avila Avails Itself of $30M, IBM Picks Up Ounce Labs, & More Boston-Area Deals News Rebecca Zacks 07/31/09 Boston
Forma and Novartis Form Cancer Drug Collaboration Ryan McBride 07/29/09 Boston
$8M More for Acquia, Novartis-Alnylam Collaboration Continues, Virtualization Firm Akiba Acquires $6.53M, & More Boston-Area Deals News Rebecca Zacks 07/24/09 Boston
Novartis Extends Alnylam Deal Ryan McBride 07/17/09 Boston
Intellikine Attracts Novartis, Biogen, and Others for $51M Second Round Ryan McBride 07/09/09 San Diego
Amgen’s Dmab Works in Cancer Trial Luke Timmerman 07/07/09 Seattle
Immuneering, Led by Young CEO and Mentor, Aims to Pick Which Cancer Drugs Should Work Luke Timmerman 07/07/09 Boston
Former CEO Alexis Borisy Voices Mixed Feelings on CombinatoRx Saga Ryan McBride 07/06/09 Boston
Intellikine, Chasing Hot Cancer Drug Target, Raises Big Venture Round Luke Timmerman 07/02/09 San Diego
Balancing Computer Security and Innovation—A Talk with RSA’s Art Coviello Wade Roush 06/29/09 Boston
Data Domain Fight Continues, Adimab Adds Merck and Roche as Partners, BigBelly Solar Gets Dirty With Waste Management, & More Boston-Area Deals News Eric Hal Schwartz 06/22/09 Boston
Inside a Life Sciences Industry Confab: Notes from Convergence Ryan McBride 06/17/09 Boston
Johnson & Johnson, TB Alliance Form Partnership to Push New TB Drug Through Clinic Luke Timmerman 06/17/09 Seattle
Merck and Roche Back Adimab, Viral Contamination Closes Genzyme Plant, Interlace Ties on $20.5M, & More Boston-Area Life Sciences News Rebecca Zacks 06/17/09 Boston
MDRNA Pays Off $5.5M Debt Luke Timmerman 06/16/09 Seattle
Novartis Backing Enlight Biosciences Ryan McBride 06/15/09 Boston
Aileron Piles on $40M, GenArts Lights Up Lucasfilm’s Screens, Taris Takes on $15M, & More Boston-Area Deals News Rebecca Zacks 06/12/09 Boston
Page 1 of 4 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.